Loading…
Simulations Plus, Inc. is projected to rise to $21.88 by 2027, a +20% move from its current price of $18.23. SLP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $18.00 | $18.24 | $18.49 | +0.08% |
| Aug 4 | $17.91 | $18.26 | $18.61 | +0.15% |
| Aug 5 | $17.85 | $18.27 | $18.71 | +0.23% |
| Aug 6 | $17.80 | $18.29 | $18.79 | +0.31% |
| Aug 7 | $17.75 | $18.30 | $18.86 | +0.39% |
| Aug 8 | $17.72 | $18.31 | $18.93 | +0.46% |
| Aug 9 | $17.68 | $18.33 | $19.00 | +0.54% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.68 | $18.33 | $19.00 | +0.54% |
| Week 2 | $17.52 | $18.43 | $19.39 | +1.09% |
| Week 3 | $17.41 | $18.53 | $19.71 | +1.64% |
| Week 4 | $17.34 | $18.63 | $20.01 | +2.19% |
| Week 5 | $17.29 | $18.73 | $20.29 | +2.74% |
| Week 6 | $17.25 | $18.83 | $20.56 | +3.30% |
| Week 7 | $17.22 | $18.93 | $20.82 | +3.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Simulations Plus, Inc. is a healthcare company that develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments.
The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. It also offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions.
Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. Simulations Plus, Inc.
was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Simulations Plus, Inc. (SLP) is a healthcare company with a current price of $18.23 per share, a market capitalization of $368.7M, and a market rank of 3184. The stock sits in the healthcare sector and reflects a position within the public equity landscape.
A major floor 37.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 1.6% above — clearing it would confirm fresh momentum.
Key SLP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SLP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.30 | Sell | $18.28 | Sell |
| MA 10 | $18.29 | Sell | $18.28 | Sell |
| MA 20 | $18.28 | Sell | $18.18 | Buy |
| MA 50 | $17.49 | Buy | $17.41 | Buy |
| MA 100 | $15.45 | Buy | $16.59 | Buy |
| MA 200 | $16.17 | Buy | $17.02 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.31 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -71.56 | Neutral |
| Williams %R (14) | -84.62 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -0.11 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 15.38 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 0.15 | Buy |
| Ultimate (7,14,28) | 47.12 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 18.30 | Sell |
| ADX (14) | 27.72 | Buy |
| ATR (14) | 0.08 | Info |
The near-term technical picture is bullish. The RSI14 is 60, with the 50-day simple moving average at $16.74 and the 200-day simple moving average at $16.05. The stock sits above a support level of $15.88 and below a resistance level of $18.39. The 30-day trading range spans from $16.15 to $20.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.36 | $18.23 | $23.58 | 0% | Neutral | |
| $17.94 | $21.88 | $27.88 | +20% | Bullish | |
| $19.59 | $24.34 | $31.87 | +34% | Bullish | |
| $23.55 | $29.72 | $39.75 | +63% | Bullish | |
| $28.77 | $36.80 | $50.11 | +102% | Bullish | |
| $33.40 | $43.25 | $59.84 | +137% | Bullish | |
| $36.79 | $48.18 | $67.60 | +164% | Bullish | |
| $39.73 | $52.58 | $74.75 | +188% | Bullish | |
| $43.03 | $57.51 | $82.74 | +215% | Bullish | |
| $44.49 | $60.04 | $87.33 | +229% | Bullish | |
| $73.72 | $103.76 | $158.20 | +469% | Bullish | |
| $161.53 | $243.86 | $398.60 | +12.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $11.36 | $18.23 | $21.73 | +0.00% |
| September 2026 | $16.13 | $18.91 | $22.66 | +3.71% |
| October 2026 | $16.61 | $19.56 | $23.63 | +3.47% |
| November 2026 | $16.45 | $19.45 | $23.64 | -0.56% |
| December 2026 | $16.27 | $19.30 | $23.58 | -0.77% |
Click any year to see its month-by-month SLP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SLP is projected to trade between $11.36 and $23.58, averaging $18.23 — a potential gain of 0% from today's $18.23. Price action looks broadly range-bound.
Simulations Plus, Inc.'s 2027 outlook centres on $21.88, within a $17.94 to $27.88 range. That is up +20% on the projected 2026 average. That marks a +20% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, SLP could reach as high as $31.87, with a base case around $24.34 and support toward $19.59 — roughly +34% from $18.23. Momentum favours further upside here.
Expect SLP to range from $23.55 to $39.75 through 2029. The $29.72 average target implies a +63% move from current prices. That is up +22% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The SLP price prediction for 2030 points to an average of $36.80 (low $28.77, high $50.11) — a potential gain of +102% on today's $18.23. Momentum favours further upside here.
In 2031, SLP is projected to trade between $33.40 and $59.84, averaging $43.25 — a potential gain of +137% from today's $18.23. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Simulations Plus, Inc.'s 2032 outlook centres on $48.18, within a $36.79 to $67.60 range. That is up +11% on the projected 2031 average. That marks a +164% change versus current levels. Momentum favours further upside here.
By 2033, SLP could reach as high as $74.75, with a base case around $52.58 and support toward $39.73 — roughly +188% from $18.23. Buyers look set to stay in control over this stretch.
Expect SLP to range from $43.03 to $82.74 through 2034. The $57.51 average target implies a +215% move from current prices. That is up +9% on the projected 2033 average. Momentum favours further upside here.
The SLP price prediction for 2035 points to an average of $60.04 (low $44.49, high $87.33) — a potential gain of +229% on today's $18.23. Buyers look set to stay in control over this stretch.
In 2040, SLP is projected to trade between $73.72 and $158.20, averaging $103.76 — a potential gain of +469% from today's $18.23. That is up +73% on the projected 2035 average. Momentum favours further upside here.
Simulations Plus, Inc.'s 2050 outlook centres on $243.86, within a $161.53 to $398.60 range. That is up +135% on the projected 2040 average. That marks a +12.4x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SLP today (≈ 54.854635 SLP) could be worth
$13,376.91
+$12,376.91 (+1238%) by 2050 · US Dollar
Based on the average projected SLP price of $243.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SLPwould be worth at today's price.
$1,000 invested in SLP on Jul 31, 2025 (≈ 76.804913 SLP) would be worth
$1,400.15
+$400.15 (+40.0%) today · 1.40× · US Dollar
Based on a SLP entry price of $13.02 vs. today's $18.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.34 | $994 | -0.6% |
| 1 month ago | $18.35 | $993.46 | -0.7% |
| 3 months ago | $14.91 | $1,222.67 | +22.3% |
| 6 months ago | $16.77 | $1,087.06 | +8.7% |
| 1 year ago | $13.02 | $1,400.15 | +40.0% |
| All time (5.0y) ago | $46.93 | $388.45 | -61.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SLP forecast.
Our base-case forecast reaches $36.00 around 2030.
Implied market cap at $36.00: $728.09M
The multi-year forecast points to sustained upside for Simulations Plus. The 2026 average price is $18.23, and the 2027 average is $21.75, 2028 $23.57, 2029 $29.13, and 2030 $35.41, supporting a bullish longer-term bias. By 2040 the forecast average rises to $94.35 and by 2050 to $219.86, with estimated ROIs of 417.6% and 1106% respectively.
The forecast also shows year-by-year growth through 2035 with rising averages and bullish sentiment, though 2026 carries neutral sentiment and later years switch to bullish. These figures are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecast shows an average price of $35.41 with a min of $27.67 and a max of $48.26, and an ROI of 94.3% with a bullish sentiment.
Forecasts show bullish sentiment in 2027-2035 with rising averages and ROIs, including a 2030 average of $35.41 and a 2040 average of $94.35, but these are estimates, not guarantees.
Yes. The forecast max values reach $48.26 in 2030 and $143.90 in 2040 and $359.45 in 2050, indicating potential to exceed $60 within the projection horizon.
Current price is $18.23 and market capitalization is $368.7M.
The near-term picture is bullish with RSI 60, SMA50 at $16.74, SMA200 at $16.05, a support of $15.88, a resistance of $18.39, and a 30-day range from $16.15 to $20.58.
Simulations Plus, Inc. Community Discussion
0Share your Simulations Plus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.